In contrast, mutations in LCAT and LIPC that increase the cholesteryl ester content of HDL without concordantly modifying reverse cholesterol transport (50, 53) lead to increased HDL-C but are associated with increased CAD. The gene discussed is LIPC; the disease is coronary artery disorder.